Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp annual/quarterly operating income history and growth rate from 2023 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Tonix Pharmaceuticals Holding Corp operating income for the quarter ending March 31, 2026 was -41.5 M, a 158.73% increase year-over-year.
• Tonix Pharmaceuticals Holding Corp operating income for the twelve months ending March 31, 2026 was -119.0 M, a 16.45% decrease year-over-year.
• Tonix Pharmaceuticals Holding Corp annual operating income for 2025 was -125.7 M, a 8.05% decrease from 2024.
• Tonix Pharmaceuticals Holding Corp annual operating income for 2024 was -136.7 M, a 15.48% increase from 2023.
• Tonix Pharmaceuticals Holding Corp annual operating income for 2023 was -118.4 M.